We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.7B
AUM Growth
+$329M
Cap. Flow
-$710M
Cap. Flow %
-4.25%
Top 10 Hldgs %
19.03%
Holding
2,687
New
132
Increased
900
Reduced
1,002
Closed
108

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$232M
2
BNL icon
Broadstone Net Lease
BNL
+$66.5M
3
APH icon
Amphenol
APH
+$64M
4
SNPS icon
Synopsys
SNPS
+$46.8M
5
XLNX
Xilinx Inc
XLNX
+$46.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$78M
2
KEYS icon
Keysight
KEYS
+$69.7M
3
ADP icon
Automatic Data Processing
ADP
+$68.4M
4
CSCO icon
Cisco
CSCO
+$60.5M
5
OMC icon
Omnicom Group
OMC
+$52.8M

Sector Composition

Rank Sector Weight
1 Technology 23.23%
2 Healthcare 13.49%
3 Financials 11.88%
4 Consumer Discretionary 9.14%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBWI icon
1451
Bath & Body Works
BBWI
$4.06B
$31K ﹤0.01%
1,237
+302
+32% +$6.17K
CTRA
1452
DELISTED
Coterra Energy
CTRA
$31K ﹤0.01%
1,827
+389
+27% +$7.27K
FORM icon
1453
FormFactor
FORM
$8.28B
$31K ﹤0.01%
1,277
+270
+27% +$7.53K
GDOT icon
1454
Green Dot
GDOT
$743M
$31K ﹤0.01%
622
+40
+7% +$2.05K
NICE icon
1455
Nice
NICE
$5.79B
$31K ﹤0.01%
137
+40
+41% +$8.51K
PLMR icon
1456
Palomar
PLMR
$3.55B
$31K ﹤0.01%
301
+180
+149% +$17.7K
VDE icon
1457
Vanguard Energy ETF
VDE
$10.1B
$31K ﹤0.01%
770
CTRE icon
1458
CareTrust REIT
CTRE
$9.91B
$30K ﹤0.01%
1,743
-272
-13% -$4.95K
EXLS icon
1459
EXL Service
EXLS
$5.14B
$30K ﹤0.01%
2,280
-30
-1% -$385
GMED icon
1460
Globus Medical
GMED
$10.7B
$30K ﹤0.01%
615
-6,246
-91% -$322K
PKG icon
1461
Packaging Corp of America
PKG
$21.9B
$30K ﹤0.01%
278
-11
-4% -$1.12K
SKYY icon
1462
First Trust Cloud Computing ETF
SKYY
$2.92B
$30K ﹤0.01%
385
VVV icon
1463
Valvoline
VVV
$4.9B
$30K ﹤0.01%
1,616
-68
-4% -$1.4K
HZNP
1464
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$30K ﹤0.01%
388
-652,194
-100% -$44.9M
ASH icon
1465
Ashland
ASH
$3.33B
$29K ﹤0.01%
415
ASR icon
1466
Grupo Aeroportuario del Sureste
ASR
$8.27B
$29K ﹤0.01%
256
+23
+10% +$2.5K
BBD icon
1467
Banco Bradesco
BBD
$39.3B
$29K ﹤0.01%
10,401
-1,066
-9% -$3.49K
BFH icon
1468
Bread Financial
BFH
$4.37B
$29K ﹤0.01%
883
-7
-0.8% -$249
ETR icon
1469
Entergy
ETR
$50.2B
$29K ﹤0.01%
602
+18
+3% +$891
FATE icon
1470
Fate Therapeutics
FATE
$286M
$29K ﹤0.01%
742
+712
+2,373% +$24.9K
FBT icon
1471
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$29K ﹤0.01%
190
FSS icon
1472
Federal Signal
FSS
$7.63B
$29K ﹤0.01%
1,021
+34
+3% +$1.05K
MFG icon
1473
Mizuho Financial
MFG
$127B
$29K ﹤0.01%
11,748
+109
+0.9% +$286
STBA icon
1474
S&T Bancorp
STBA
$1.84B
$29K ﹤0.01%
1,731
-19
-1% -$395
ZTO icon
1475
ZTO Express
ZTO
$18.3B
$29K ﹤0.01%
1,001
+343
+52% +$11.7K

Similar funds

Glenmede Trust's Q3 2020 Portfolio in Review

As of Q3 2020, Glenmede Trust held 2,687 positions worth $16.7B, up 2% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glenmede Trust withdrew a net $710M in Q3 2020, closing 108 positions and reducing 1,002 holdings. Its most notable exit was IBERIABANK Corp, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Broadstone Net Lease worth $67.3M.

  • Glenmede Trust's largest Q3 2020 buy was Broadstone Net Lease: 4,009,897 shares worth $67.3M.
  • Glenmede Trust added most to Progressive in Q3 2020, an estimated $232M increase.
  • Glenmede Trust's biggest Q3 2020 reduction was Apple, cutting an estimated $78M.
  • Glenmede Trust fully exited IBERIABANK Corp in Q3 2020, selling an estimated $18.1M.
  • Glenmede Trust's ten largest holdings make up 19% of its $16.7B portfolio in Q3 2020.
  • Glenmede Trust opened 132 new positions and closed 108 in Q3 2020.
  • Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $16.7B.

Based on Glenmede Trust's 13F filing for Q3 2020, filed 16 Nov 2020.